483
Maxwell B. Sauder, M.D.FDA 483 - Maxwell B. Sauder, M.D. - April 06, 2023
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Record Details
The FDA inspected Maxwell B. Sauder, M.D. at the Toronto Research Centre, identifying a significant issue with the maintenance of accurate case histories. The firm failed to report adverse events and concomitant medications to the study sponsor, including some events potentially related to the investigational product and medications requiring washout periods. This indicates a failure in critical reporting procedures for clinical investigations.
Open in Dashboard
ID · 1a1a8213-1a9b-4689-b734-27ec063debf5